

Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $22.01
Latest analyst grade actions
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 64.00 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 91.97 | Oscillator | Sell |
| Williams %R (14) | -11.96 | Oscillator | Sell |
| MACD (12, 26, 9) | 2.07 (Hist 1.56) | Oscillator | Strong Buy |
| Average Directional Index (14) | 31.56 (+DI 52.9 / -DI 32.9) | Trend | Strong Buy |
| EMA 20 | 12.71 | MA | Strong Buy |
| SMA 20 | 11.20 | MA | Strong Buy |
| EMA 50 | 11.35 | MA | Strong Buy |
| SMA 50 | 11.09 | MA | Strong Buy |
| SMA 200 | 10.67 | MA | Strong Buy |
FY2024 · 10-K disclosure
Stock news · updated daily
Cencora to acquire American Oncology Network in $2.4 billion deal
CONSHOHOCKEN, Pa. & FORT MYERS, Fla.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced it has signed a definitive agreement to acquire American Oncology Network, Inc. (“AON”) (OTCQX: AONC), a physician-led network of more than 350 oncology providers across 21 states. “The acquisition of AON will expand our physician-led oncology MSO and support of care in communities across the country,” said Robert P. Mauch, President and Chief Executive Officer of Cencora. “AON serves as a trusted p.
COLUMBUS, Ohio, Aug. 25, 2026 (GLOBE NEWSWIRE) -- Zangmeister Cancer Center, a partner practice of American Oncology Network, is hosting Hope Grows Here: A Survivor Celebration to honor cancer survivors and their journeys. The event will feature guest speakers, activities and demonstrations for cancer survivors and their families.
American Oncology Network, Inc. (OTCMKTS:AONC - Get Free Report) traded down 0.1% during trading on Tuesday. The company traded as low as $7.00 and last traded at $9.99. 1,000 shares traded hands during trading, an increase of 45% from the average session volume of 688 shares. The stock had previously closed at $10.00. American
HOUSTON, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Oncology Consultants (OC), a partner practice of American Oncology Network (AON), is pleased to welcome Board-certified medical oncologist Asad Haider, MD, to its physician team. Dr. Haider is accepting patients at the practice's Northeast, Cypress and Willowbrook locations.
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Mar 27, 2025 | — | -0.00 | — | $490.9M |
| Nov 13, 2024 | — | -0.19 | — | $470.3M |
| Aug 14, 2024 | — | 0.12 | — | $434.0M |
| Sep 30, 2023 | — | -0.27 | — | $336.3M |
SEC EDGAR filings · last 12 months
Proxy statement (DEF 14A) disclosures
TTM vs. 5-year historical average (annual ratios)
| Metric | AONC | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | -31.9x | -747.4x · sector 20.7x | Discount |
| Forward P/E | — | — | n/a |
| Price / Book | 15.8x | 2374.8x | Discount |
| Price / Sales | 0.4x | 0.3x | Elevated |
| EV / EBITDA | 401.3x | 34.1x | Elevated |
| Return on equity | 5.6% | — | Weak |
| Gross margin | 6.7% | 7.8% | In line |
| Debt / Equity | 7.85 | 1.86 | Levered |
| Piotroski / Altman Z | 3/9 | Z 4.60 | Safe zone |
Discounted cash flow model
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Jul 16, 24 | Valle William | director | A-Award | 5,000 | — |
| Jul 16, 24 |
| Fluegel Bradley M |
| director |
| A-Award |
| 5,000 |
| — |
| Jul 16, 24 | Divers Stephen | director, officer: Chief Medical Officer | A-Award | 36,000 | — |
| Jul 16, 24 | Mallon Erica | officer: General Counsel | A-Award | 36,000 | — |
| Jul 16, 24 | Afshar David | officer: Chief Financial Officer | A-Award | 150,000 | — |
| Jul 16, 24 | Schonherz Todd | director, officer: Chief Executive Officer | A-Award | 300,000 | — |
| Jun 3, 24 | Afshar David | officer | 0 | — |
| May 24, 24 | Divers Stephen | director, officer: Chief Medical Officer | P-Purchase | 5,000 @ $2.15 | $10.75K |